Skip to main content
SpringerLink
Log in

Atypical features and treatment choices in bipolar disorders: a result of the National Bipolar Mania Pathway Survey in China

  • Original Article
  • Published:
Neuroscience Bulletin Aims and scope Submit manuscript

Abstract

In this study, we examined the point prevalence rate of atypical features in bipolar disorder, and estimated the potential impact of these features on treatment practices in China. Using the atypical features criteria of the Diagnostic and Statistical Manual of the American Psychiatric Association (DSM-IV), we documented the atypical symptoms in 3 906 consecutive participants with bipolar disorder enrolled at 26 psychiatric services across China. We further assessed the association between atypical features and the treatment approaches, including the prescription of antidepressants. The overall point prevalence rate of atypical features was 9.1% among patients with various bipolar disorder subtypes. When the definition was broadened to include atypical features B, the overall rate increased to 11.8%. Interestingly, among patients with the mixed state and remission subtypes, there was a significant difference in the rates of antidepressant medication usage between patients who met and those who did not meet the criteria for atypical features B. These findings indicate a trend of using antidepressants for these two types of patients with atypical features. Further, for both mixed state and remission patients, treatment approaches were related to atypical features B. Our findings provide evidence to assist clinicians to readily recognize atypical features in bipolar subtypes and can propose treatments based on these diagnoses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Psychiatric Association. Task force on DSM-IV. Diagnostic and statistical manual of mental disorders: DSMIV-TR. 4th ed. American Psychiatric Association 2000: 41–48.

    Google Scholar 

  2. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rossler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 2003, 73: 133–146.

    Article  PubMed  Google Scholar 

  3. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003, 73: 123–131.

    Article  PubMed  Google Scholar 

  4. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007, 64: 543–552.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011, 68: 241–251.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA 1990, 264: 2511–2518.

    Article  CAS  PubMed  Google Scholar 

  7. Phillips MR, Zhang J, Shi Q, Song Z, Ding Z, Pang S, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet 2009, 373: 2041–2053.

    Article  PubMed  Google Scholar 

  8. Asnis GM, McGinn LK, Sanderson WC. Atypical depression: clinical aspects and noradrenergic function. Am J Psychiatry 1995, 152: 31–36.

    Article  CAS  PubMed  Google Scholar 

  9. Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 1996, 53: 391–399.

    Article  CAS  PubMed  Google Scholar 

  10. Rabkin JG, Stewart JW, Quitkin FM, McGrath PJ, Harrison WM, Klein DF. Should atypical depression be included in DSM-IV. DSM-IV Sourcebook 1996, 2: 239–260.

    Google Scholar 

  11. Benazzi F. Atypical depression in private practice depressed outpatients: a 203-case study. Compr Psychiatry 1999, 40: 80–83.

    Article  CAS  PubMed  Google Scholar 

  12. Benazzi F. Should mood reactivity be included in the DSM-IV atypical features specifier? Eur Arch Psychiatry Clin Neurosci 2002, 252: 135–140.

    Article  PubMed  Google Scholar 

  13. Perugi G, Akiskal HS, Lattanzi L, Cecconi D, Mastrocinque C, Patronelli A, et al. The high prevalence of “soft” bipolar (II) features in atypical depression. Compr Psychiatry 1998, 39: 63–71.

    Article  CAS  PubMed  Google Scholar 

  14. Posternak MA, Zimmerman M. The prevalence of atypical features across mood, anxiety, and personality disorders. Compr Psychiatry 2002, 43: 253–262.

    Article  PubMed  Google Scholar 

  15. Thase ME. Recognition and diagnosis of atypical depression. J Clin Psychiatry 2007, 68 Suppl 8: 11–16.

    Google Scholar 

  16. Akiskal HS, Walker P, Puzantian VR, King D, Rosenthal TL, Dranon M. Bipolar outcome in the course of depressive illness: phenomenologic, familial, and pharmacologic predictors. J Affect Disord 1983, 5: 115–128.

    Article  CAS  PubMed  Google Scholar 

  17. Robertson HA, Lam RW, Stewart JN, Yatham LN, Tam EM, Zis AP. Atypical depressive symptoms and clusters in unipolar and bipolar depression. Acta Psychiatr Scand 1996, 94: 421–427.

    Article  CAS  PubMed  Google Scholar 

  18. Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 1988, 145: 306–311.

    Article  CAS  PubMed  Google Scholar 

  19. Sotsky SM, Simmens SJ. Pharmacotherapy response and diagnostic validity in atypical depression. J Affect Disord 1999, 54: 237–247.

    Article  CAS  PubMed  Google Scholar 

  20. Stewart J, Thase M. Treating DSM-IV depression with atypical features. J Clin Psychiatry 2007, 68: e10–e10.

    Article  PubMed  Google Scholar 

  21. Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004, 161: 1537–1547.

    Article  PubMed  Google Scholar 

  22. Sachs GS, Nierenberg AA, Calabrese JR, Marangell LB, Wisniewski SR, Gyulai L, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007, 356: 1711–1722.

    Article  CAS  PubMed  Google Scholar 

  23. American Psychiatric Association. Pra ctice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002, 159: 4.

    Google Scholar 

  24. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller HJ, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 2013, 14: 154–219.

    Article  PubMed  Google Scholar 

  25. National Collabor ating Centre for Mental Health. Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children, and Adolescents. Primary and Secondary Care. Leicester, UK: British Psychological Society 2006.

    Google Scholar 

  26. Shen Q, Liu T, Zhan H, Ma X, Wang G, Tian C. Practice guideline for prevention and treatment of bipolar disorder (in Chinese). Beijing (China): Chinese Medical Association 2007.

    Google Scholar 

  27. Si T, Shu L, Yu X, Ma C, Wang G, Bai P, et al. A crosssectional study on treatment patterns of bipolar disorders in China in 2006. Chin J Psychiatry 2012, 45: 29–34.

    Google Scholar 

  28. Angst J, Gamma A, Bowden C, Azorin J, Perugi G, Vieta E, et al. Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci 2012, 262: 3–11.

    Article  CAS  PubMed  Google Scholar 

  29. Benazzi F. Prevalen ce of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord 1997, 43: 163–166.

    Article  CAS  PubMed  Google Scholar 

  30. Benazzi F. Sensitivi ty and specificity of clinical markers for the diagnosis of bipolar II disorder. Compr Psychiatry 2001, 42: 461–465.

    Article  CAS  PubMed  Google Scholar 

  31. Benazzi F. Bipolar di sorder-focus on bipolar II disorder and mixed depression. Lancet 2007, 369: 935–945.

    Article  PubMed  Google Scholar 

  32. Chen FZ, Xiang YT, Lu Z, Wang G, Hu C, Kilbourne AM, et al. Characteristics of unrecognised bipolar disorder in patients treated for major depressive disorder in china: general versus psychiatric hospitals. East Asian Arch Psychiatry 2013, 23: 139–143.

    CAS  PubMed  Google Scholar 

  33. Carta MG, Aguglia E, Balestrieri M, Calabrese JR, Caraci F, Dell'Osso L, et al. The lifetime prevalence of bipolar disorders and the use of antidepressant drugs in bipolar depression in Italy. J Affect Disord 2012, 136: 775–780.

    Article  PubMed  Google Scholar 

  34. Goldberg JF, Brooks JO, 3rd, Kurita K, Hoblyn JC, Ghaemi SN, Perlis RH, et al. Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry 2009, 70: 155–162.

    Article  PubMed  Google Scholar 

  35. Greil W, Haberle A, Haueis P, Grohmann R, Russmann S. Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. J Affect Disord 2012, 136: 534–542.

    Article  PubMed  Google Scholar 

  36. Albert Y. The use of antide pressants for treating bipolar depression: a clinical controversy. Shanghai Arch Psychiatry 2011, 23: 175–177.

    Google Scholar 

  37. Geddes JR, Miklowitz DJ. Tre atment of bipolar disorder. Lancet 2013, 381: 1672–1682.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Mood Disorders, Shanghai Clinical Center for Mental Disorder, Department of Psychiatry, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200030, China

    Daihui Peng, Ting Shen, Chen Zhang, Yueqi Huang & Yiru Fang

  2. School of Psychology (Burwood Campus), Deakin University, Melbourne, Australia

    Linda Byrne, Marita McCabe & David Mellor

  3. Institute of Mental Health, Peking University, Beijing, 100191, China

    Xin Yu

  4. Mental Health Institute, The Second Xiangya Hospital of Central South University, Changsha, 410011, China

    Jingping Zhao

Authors
  1. Daihui Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ting Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Linda Byrne
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chen Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yueqi Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xin Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jingping Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marita McCabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. David Mellor
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yiru Fang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yiru Fang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Peng, D., Shen, T., Byrne, L. et al. Atypical features and treatment choices in bipolar disorders: a result of the National Bipolar Mania Pathway Survey in China. Neurosci. Bull. 31, 22–30 (2015). https://doi.org/10.1007/s12264-014-1487-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12264-014-1487-3

Keywords

Search

Navigation